TerrAscend (TSNDF) Liabilities from Discontinued Operations (2021 - 2026)
TerrAscend's (TSNDF) quarterly Liabilities from Discontinued Operations came in at 6881000.0 in Q1 2026, down 45.46% on a QoQ basis from 12616000.0 in Q4 2025.
TerrAscend (TSNDF) Liabilities from Discontinued Operations (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 6 years of Liabilities from Discontinued Operations data on file, last reported at 6881000.0 in Q1 2026.
- On a quarterly basis, Liabilities from Discontinued Operations changed N/A year-over-year to 6881000.0 in Q1 2026; TTM through Mar 2026 was 6881000.0, a N/A change from a year earlier, with the FY2025 full-year figure at 12616000.0, down 48.08% from the prior year.
- Liabilities from Discontinued Operations for Q1 2026 stood at 6881000.0, down from 12616000.0 in the prior quarter.
- Over the last five years, Liabilities from Discontinued Operations for TSNDF reached as high as 24298000.0 in Q4 2024 and fell as low as 1124000.0 in Q3 2023.
- Historically, Liabilities from Discontinued Operations has averaged 11312333.33 across 5 years, with a median of 9111000.0 in 2022.
- Across the five-year window, Liabilities from Discontinued Operations gained 12.87% in 2022 and plunged 48.08% in 2025, its largest moves.
- Year by year, Liabilities from Discontinued Operations stood at 9111000.0 in 2022, then tumbled by 87.66% to 1124000.0 in 2023, then jumped by 2061.74% to 24298000.0 in 2024, then sank by 48.08% to 12616000.0 in 2025, then plunged by 45.46% to 6881000.0 in 2026.
- Per Business Quant data, the three most recent Liabilities from Discontinued Operations figures were 6881000.0 in Q1 2026, 12616000.0 in Q4 2025, and 14856000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | TerrAscend | 160.44 Mn | 162.98 Mn | 34.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.88 Mn |
| Mar 31, 2026 | 6.88 Mn |
| Dec 31, 2025 | 12.62 Mn |
| Dec 31, 2025 | 12.62 Mn |
| Sep 30, 2025 | 14.86 Mn |
| Sep 30, 2025 | 14.86 Mn |
| Jun 30, 2025 | 23.99 Mn |
| Jun 30, 2025 | 23.99 Mn |
| Dec 31, 2024 | 24.30 Mn |
| Dec 31, 2024 | 24.30 Mn |
| Sep 30, 2023 | 1.12 Mn |
| Sep 30, 2023 | 1.12 Mn |
| Jun 30, 2023 | 1.47 Mn |
| Jun 30, 2023 | 1.47 Mn |
| Mar 31, 2023 | 7.47 Mn |
| Mar 31, 2023 | 7.47 Mn |
| Dec 31, 2022 | 9.11 Mn |
| Dec 31, 2022 | 9.11 Mn |
| Dec 31, 2021 | 8.07 Mn |
| Dec 31, 2021 | 8.07 Mn |